Progress in development of recombinant human enterotoxigenic Escherichia coli vaccine

Chinese Journal of Biologicals

Volumn 23, Issue 5, 2010, Pages 544-548

  Wang, Rong Rong ^a   Ma, Yong Ping ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Diarrhea; Enterotoxigenic escherichia coli (ETEC); Enterotoxin; Pilin; Recombinant vaccine

Indexed keywords

DNA; ENTEROTOXIGENIC ESCHERICHIA COLI VACCINE; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI VACCINE; PILIN; UNCLASSIFIED DRUG;

ARTICLE; DIARRHEA; DRUG RESEARCH; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENETIC TRANSFORMATION; HUMAN; INFECTION PREVENTION; NONHUMAN; VACCINATION; VACCINE PRODUCTION;

ESCHERICHIA COLI;

EID: 77953451822     PISSN: 10045503     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Clements JD, El-Morshidy S. Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas. Infect Immun, 1984,46(2):564-569. (Pubitemid 15204636)
2. Paccez JD, Luiz WB, Sbrogio-Almeida ME, et al. Stable episomal expression system under control of a stress inducible promoter enhances the immunogenicity of Bacillus subtilis as a vector for antigen delivery. Vaccine, 2006,24(15):2935-2943.
3. Rezaee MA, Rezaee A, Moazzeni SM, et al. Expression of Escherichia coli heat-labile enterotoxin B subunit (LTB) in Saccharomyces cerevisiae. J Microbiol, 2005,43(4):354-360. (Pubitemid 41329719)
4. Pereira CM, Guth BE, Sbrogio-Almeida ME, et al. Antibody response against Escherichia coli heat-stable enterotoxin expressed as fusions to flagellin. Microbiology, 2001,147(Pt4):861-867. (Pubitemid 32401326)
5. Amin T, Hirst TR. Purification of the B-subunit oligomer of Escherichia coli heat-labile enterotoxin by heterologous expression and secretion in a marine vibrio. Protein Expr Purif, 1994,5(2): 198-204. (Pubitemid 2084535)
6. Wu S, Pascual DW, VanCott JL, et al. Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR. Infect Immun, 1995,63(12):4933-4938.
7. Tobias J, Lebens M, Bölin I, et al. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae. Vaccine, 2008,26(6):743-752.
8. Turner AK, Beavis JC, Stephens JC, et al. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I. Infect Immun, 2006,74 (2):1062-1071.
9. Ranallo RT, Fonseka CP, Cassels F, et al. Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608 (pCFAI) and SC608 (pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli. Infect Immun, 2005,73(1): 258-267.
10. Alves AM, Lasáro MO, Almeida DF, et al. DNA immunisation against the CFA/I fimbriae of enterotoxigenic Escherichia coli (ETEC). Vaccine, 2000,19(7-8):788-795.
11. Alves AM, Lasaro MO, Almeida DF ,et al. Epitope specificity of antibodies raised against enterotoxigenic Escherichia coli CFA/I fimbriae in mice immunized with naked DNA. Vaccine, 1998,16 (1):9-15.
12. Guillobel HC, Luna MG, Camacho EF, et al. Immunization against the colonization factor antigen I of enterotoxigenic Escherichia coli by administration of a bivalent Salmonella typhimurium aroA strain. Braz J Med Biol Res, 1998,31(4):545-554.
13. Lüdi S, Frey J, Favre D, et al. Assessing the expression of enterotoxigenic Escherichia coli-specific surface antigens in recombinant strains by transmission electron microscopy and immunolabeling. J Histochem Cytochem, 2006,54(4):473-477.
14. Altboum Z, Levine MM, Galen JE, et al. Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain. Infect Immun, 2003,71(3):1352-1360. (Pubitemid 36254321)
15. Altboum Z, Barry EM, Losonsky G, et al. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection. Infect Immun, 2001,69(5):3150-3158. (Pubitemid 32332211)
16. Favre D, Lüdi S, Stoffel M, et al. Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae. Vaccine, 2006,24(20):4354-4368.
17. Turner AK, Terry TD, Sack DA, et al. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect Immun, 2001,69(8):4969-4979.
18. Koprowski H 2nd, Levine MM, Anderson RJ, et al. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli. Infect Immun, 2000,68(9):4884-4892.
19. Zhuang J, You YJ, Chen B, et al. The immune responses of the fusion protein consisted of two copies of T-cell and B-cell epitopes of food-and-mouth disease virus VPI type O and LTB and STI enterotoxins of Escherichia coli. Yi Chuan, 2006,28(5): 557-562.
20. Bai JN, Sun YM, Bian YQ, et al. Contruction of the genetic engineering strain expressed nontoxic STI-LTB fusion protein against enterotoxigenic Escherichia coli. Agric Sci Chin, 2004,3(7): 535-540.
21. Teng J, Rui X, Zhang Y, et al. Stable expression and immunogenicity in a attenuated Salmonella typhi strain of coli surface antigen-6 of enterotoxigenic Escherichia coli. Wei Sheng Wu Xue Bao, 1999,39(6):533-538.
22. Zheng JP, Zhang ZS, Li SQ, et al. Construction of a novel Shigella live-vector strain co-expressingCS3 and LTB/STm of enterotoxigenic E. coli. World J Gastroenterol, 2005,11(22):3411-3418.